Blankenberge, Belgium Clinical Trials

A listing of Blankenberge, Belgium clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 132 clinical trials
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

The objective of this study is to verify the safety and efficacy of the investigational device (ELX1805J) for the treatment of ischemic heart disease due to de novo, native coronary artery lesions

AZ Sint Jan Brugge
 (8.1 away) Contact site
  • 25 Apr, 2021
  • +35 other locations
A Study of TAR-200 in Combination With Cetrelimab TAR-200 Alone or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

The purpose of this study is to evaluate the overall complete response (CR) rate in participants treated with TAR-200 in combination with cetrelimab (Cohort 1), or TAR-200 alone (Cohort 2), or cetrelimab alone (Cohort 3) with Carcinoma in Situ (CIS), with or without concomitant high-grade Ta or T1 papillary disease.

bladder tumor
invasive bladder cancer
carcinoma in situ
AZ St.-Jan Brugge-Oostende AV
 (6.4 away) Contact site
  • 28 May, 2021
  • +174 other locations
Patient Reported Outcome Measures (PROMs) in Rehabilitation With or Without the Possible Use of a Mobile Application After Primary Knee or Hip Arthroplasty

Rehabilitation after primary knee or hip arthroplasty traditionally includes performing exercises with a physiotherapist. For patients who can work well with a computer, tablet or smartphone, it is now possible to use a mobile application (e.g. moveUp) to carry out a large part of the exercises more independently. This is …

AZ Sint-Jan Brugge
 (6.4 away) Contact site
  • 28 Jan, 2021
  • +13 other locations
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB Subtype DLBCL (ACE-LY-312)

Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects 65 years of age with previously untreated non-germinal center diffuse large B-cell lymphoma.

Research site
 (6.4 away) Contact site
  • 09 Jun, 2021
  • +214 other locations
A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

The primary purpose of this study is to determine: the recommended Phase 2 doses (RP2Ds) of JNJ-64264681 and JNJ 67856633 when administered together in participants with B cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) (Part A - Dose Escalation); and the safety of the RP2Ds for this combination …

chronic lymphocytic leukemia
AZ St.-Jan Brugge-Oostende AV
 (6.4 away) Contact site
  • 28 May, 2021
  • +32 other locations
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

To evaluate the efficacy of AKCEA-TTR-LRx compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit

Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
 (6.4 away) Contact site
  • 16 May, 2021
  • +73 other locations
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works in patients with irregular heartbeat (atrial fibrillation) that can lead to blood clots, stroke and other heart-related complications. …

AZ St-Jan Brugge Oostende AV
 (6.4 away) Contact site
  • 21 May, 2021
  • +140 other locations
Evaluate the Safety and Performance of the AccuCinch Ventricular Repair System - The CorCinch-EU Study

This is prospective, non-randomized, single-arm, international, multicenter, clinical safety and performance clinical investigation to evaluate the AccuCinch Ventricular Repair System for the treatment of heart failure, with or without functional mitral regurgitation due to dilated ischemic or non-ischemic cardiomyopathy

ejection fraction
mitral valve repair
heart failure
functional mitral regurgitation
left ventricular remodeling
AZ Sint-Jan Brugge
 (8.1 away) Contact site
  • 04 Jun, 2021
  • +30 other locations
PREMOM II: Pregnancy Remote Monitoring of Women With Gestational Hypertensive Disorders

The goal of this project is thoroughly evaluate the added value of telemonitoring (TM) program for women at risk for gestational hypertensive disorders (GHD), by investigating it impact on prenatal follow-up, health outcomes for mother and child, costs and satisfaction, and by specifically investigating what are the major contributors to …

AZ Sint-Lucas Brugge - Oostende
 (6.4 away) Contact site
  • 24 Jan, 2021
  • +3 other locations
Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

to evaluate the feasibility, safety and performance of the HighLife 28mm Transcatheter Mitral Valve in patients with moderate-severe or severe mitral regurgitation who are at high risk for surgical treatment.

medical therapy
heart surgery
mitral valve replacement
AZ Sint-Jan
 (6.4 away) Contact site
  • 04 Jun, 2021
  • +31 other locations